MARASCA, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.604
AS - Asia 11.232
EU - Europa 10.811
SA - Sud America 1.475
AF - Africa 148
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 19
Totale 51.333
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.328
GB - Regno Unito 4.343
HK - Hong Kong 3.528
CN - Cina 3.062
SG - Singapore 2.660
IT - Italia 1.670
BR - Brasile 1.217
SE - Svezia 1.215
DE - Germania 973
VN - Vietnam 580
RU - Federazione Russa 564
FI - Finlandia 535
UA - Ucraina 500
TR - Turchia 405
KR - Corea 224
BG - Bulgaria 211
FR - Francia 208
ID - Indonesia 186
IN - India 164
CA - Canada 159
AR - Argentina 93
NL - Olanda 84
IE - Irlanda 77
JP - Giappone 73
BD - Bangladesh 69
ES - Italia 69
MX - Messico 61
PL - Polonia 58
ZA - Sudafrica 53
CZ - Repubblica Ceca 51
BE - Belgio 50
EC - Ecuador 50
AT - Austria 46
AU - Australia 41
IQ - Iraq 41
LT - Lituania 36
PK - Pakistan 32
CL - Cile 31
MY - Malesia 28
IR - Iran 24
MA - Marocco 24
VE - Venezuela 21
CO - Colombia 20
AE - Emirati Arabi Uniti 19
BZ - Belize 19
RO - Romania 18
UZ - Uzbekistan 18
EG - Egitto 16
EU - Europa 15
PY - Paraguay 15
SA - Arabia Saudita 14
AZ - Azerbaigian 13
SK - Slovacchia (Repubblica Slovacca) 13
IL - Israele 12
KE - Kenya 12
CH - Svizzera 11
TN - Tunisia 11
PE - Perù 10
PH - Filippine 10
DZ - Algeria 9
SI - Slovenia 9
BO - Bolivia 8
DK - Danimarca 8
GR - Grecia 8
JM - Giamaica 8
RS - Serbia 8
UY - Uruguay 8
LB - Libano 7
NP - Nepal 7
TW - Taiwan 7
AL - Albania 6
KG - Kirghizistan 6
LK - Sri Lanka 6
LV - Lettonia 6
OM - Oman 6
PA - Panama 6
PT - Portogallo 6
HN - Honduras 5
JO - Giordania 5
MK - Macedonia 5
BA - Bosnia-Erzegovina 4
CR - Costa Rica 4
ET - Etiopia 4
KZ - Kazakistan 4
MD - Moldavia 4
NG - Nigeria 4
BY - Bielorussia 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
KW - Kuwait 3
LU - Lussemburgo 3
NO - Norvegia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
BW - Botswana 2
CY - Cipro 2
GA - Gabon 2
Totale 51.293
Salva come PNG Salva come JPEG
Città #
Hong Kong 3.515
Fairfield 3.248
Southend 3.187
Ashburn 2.466
Santa Clara 2.295
Woodbridge 1.877
Singapore 1.682
Ann Arbor 1.651
Houston 1.482
Chandler 1.447
Seattle 1.254
Wilmington 1.068
Cambridge 1.017
Hefei 983
Jacksonville 975
Dearborn 838
Nyköping 746
London 633
Beijing 496
Los Angeles 480
Chicago 447
Modena 417
New York 338
Helsinki 324
San Diego 301
Princeton 247
Buffalo 232
Izmir 227
Seoul 216
Sofia 208
Ho Chi Minh City 195
Eugene 189
Munich 184
Salt Lake City 183
The Dalles 165
Moscow 157
Jakarta 151
Council Bluffs 125
Shanghai 122
Milan 119
Fremont 112
Dallas 104
Hanoi 103
San Jose 101
São Paulo 98
Tampa 96
Bremen 90
Bologna 86
Elk Grove Village 80
Redwood City 79
Columbus 76
Dublin 73
Rome 68
Phoenix 67
Boardman 66
Frankfurt am Main 64
Des Moines 63
Dong Ket 57
Tokyo 57
Toronto 50
Atlanta 49
Brooklyn 49
Brussels 49
Falls Church 49
Nuremberg 48
Guangzhou 46
Lancaster 45
Warsaw 45
Montreal 44
Norwalk 43
Kent 41
Denver 38
Miami 37
Orem 37
Kunming 36
Rio de Janeiro 36
Stockholm 33
Turku 33
Brno 32
Kilburn 31
Philadelphia 31
Nanjing 30
Dulles 29
Redondo Beach 29
Chennai 28
Poplar 28
San Francisco 28
Sterling 28
Boston 27
Las Vegas 27
Reggio Emilia 27
Vienna 27
Johannesburg 26
Parma 26
Belo Horizonte 25
Jinan 25
Albuquerque 24
Haiphong 24
San Mateo 24
Melbourne 23
Totale 38.834
Salva come PNG Salva come JPEG
Nome #
Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features. 780
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study) 558
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 531
SVILUPPO DI IPOGAMMAGLOBULINEMIA IN PAZIENTI TRATTATI CON IMATINIB PER LEUCEMIA MIELOIDE CRONICA O TUMORI STROMALI GASTROINTESTINALI 386
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 380
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 365
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor 365
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 357
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 345
Bone marrow failure associated with human herpesvirus 8 infection after transplantation 340
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 335
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 335
Human herpesvirus-8 DNA sequences in Human Immunodeficiency Virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity 331
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells 328
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 327
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 325
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 320
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line 312
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 310
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 310
Chronic myeloid leukemia with thrombocythemic onset may be associated with different BCR/ABL variant transcripts 306
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 299
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 299
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 298
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 294
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 291
Lenalidomide Combination Therapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma: The Italian Real-Life Experience 290
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 288
Mucorales-specific T cells in patients with hematologic malignancies 287
Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with Flt3 mutational status 283
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 283
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 283
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis 282
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 281
Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience 280
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 280
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 278
Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma 276
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. 276
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 273
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia 272
Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis 271
The genetics of nodal marginal zone lymphoma 271
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 268
Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance 268
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 266
Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura. 264
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: The growing saga of the IGHV3 subgroup gene usage 263
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia 263
Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia 263
Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status 262
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 260
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 260
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 258
Molecular prediction of durable remission after first-line fludarabinecyclophosphamide-rituximab in chronic lymphocytic leukemia 256
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 256
Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. 255
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 255
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 255
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 254
NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL 254
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials 254
Missense mutations in the PML/RAR alpha ligand binding domain in ATRA-resistant As2O3 sensitive relapsed acute promyelocytic leukemia 253
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 252
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 251
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes 251
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia. 250
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma 250
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 249
Distinct genomic events in the myeloid and lymphoid lineages in simultaneous presentation of chronic myeloid leukemia and B-chronic lymphocytic leukemia 248
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 248
3 CASES OF HUMAN HERPESVIRUS-6 LATENT INFECTION - INTEGRATION OF VIRAL GENOME IN PERIPHERAL-BLOOD MONONUCLEAR CELL-DNA 247
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding 246
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 244
Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study 243
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. 241
Strikingly homologous immunoglobulin gene rearrangements and poor outcome inV(H)3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status 240
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 240
Immunoglobulin mutational status detected through single-round amplification of partial VH region, represents a good prognostic marker for the clinical outcome in chronic lymphocytic leukemia 239
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections 239
INCIDENCE AND SURVIVAL OF MYELOID MALIGNANCIES IN 1102 PATIENTS IN PROVINCE OF MODENA, NORTHERN ITALY 238
Peripheral lymphadenopathy: role of excisional biopsy in differential diagnosis based on a five-year experience. 238
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 237
Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo 236
Additional neoplasms and HCV infection in low-grade lymphoma of MALT type 236
P53 GENE POINT MUTATIONS IN RELATION TO P53 NUCLEAR-PROTEIN ACCUMULATION IN COLORECTAL CANCERS 235
The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes 234
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 233
Gestational thrombocytopenia - Reply 232
HHV-8-associated primary cerebral B-cell lymphoma in HIV-negative patient after long-term steroids 232
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival 231
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 231
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines 230
Cellular localization of human herpesvirus 8 in nonneoplastic lymphadenopathies and chronic interstitial pneumonitis by in situ polymerase chain reaction studies 229
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 229
Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene 229
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study 229
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout” 229
The oncogenic 30 and 69 bp deletion variants of the EBV LMP-1 gene are common in HIV-negative lymphoproliferations, both malignant and benign 229
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia 228
Totale 28.191
Salva come PNG Salva come JPEG
Categoria #
all - tutte 212.265
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 212.265
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.200 0 0 0 0 0 480 367 674 244 676 397 362
2021/20224.275 197 548 517 206 99 235 259 192 398 307 698 619
2022/20234.255 503 482 325 374 579 570 81 445 488 51 190 167
2023/20242.972 104 162 172 272 562 270 349 452 54 68 188 319
2024/202510.787 313 123 141 682 1.580 1.278 624 450 2.867 445 985 1.299
2025/202610.115 1.227 1.274 1.683 2.054 2.619 1.258 0 0 0 0 0 0
Totale 51.856